WTA: Chris Evert receiving treatment for cancer recurrence

Date:

Share post:


Tennis great Chris Evert is dealing with a recurrence of ovarian cancer, and treatments will keep her off television broadcasts of the upcoming Australian Open.

“While this is a diagnosis I never wanted to hear, I once again feel fortunate that it was caught early,” Evert said in a statement issued through ESPN, for whom she is an analyst. “Doctors found cancer cells in the same pelvic region. All cells were removed, and I have begun another round of chemotherapy.

“I will be unable to join my colleagues when ESPN makes its return to Melbourne for the Australian Open next month. But I’ll be ready for the rest of the Grand Slam season!

“I encourage everyone to know your family history and advocate for yourself. Early detection saves lives. Be thankful for your health this holiday season.”

Evert, 68, was first diagnosed with ovarian cancer in 2021.

Evert captured 18 career Grand Slam singles titles: two at the Australian Open, seven at the French Open, three at Wimbledon and six at the U.S. Open. She added three major doubles championships and helped the United States win the Fed Cup eight times.

After a pro career that ran from 1972-89, Evert was enshrined in the International Tennis Hall of Fame in 1995.

–Field Level Media

spot_img

Related articles

WTA: Serena Williams denies potential return to pro tennis

Former World No. 1 Serena Williams denied she is planning a potential return to professional tennis. "Omg yall I'm...

ATP: Italy clinches 3rd straight Davis Cup with sweep of Spain

Italy became the first country to win three consecutive Davis Cups since the United States between 1968-72 with...

ATP: Spain upsets Germany to reach Davis Cup Finals

The doubles team of Marcel Granollers and Pedro Martinez won the deciding match to propel underdog Spain to...

ATP: Flavio Cobolli’s heroics send Italy back to Davis Cup final

Italy is one win away from three-peating as Davis Cup champions, as the host nation swept Belgium 2-0...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.